Skip to content
BALTYMAS logo — Excellence in native recombinant proteins

BALTYMAS

Excellence in native recombinant proteins

Founded 2011 Lithuania Lithuania 4 employees Biotechnology, Health Care +1

General Information

Company Name BALTYMAS
Founded Year 2011
Location Lithuania Lithuania
Employees 4
Industries Biotechnology, Health Care, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with BALTYMAS. To contact BALTYMAS, visit baltymas.lt.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BALTYMAS compare?

A PDF of BALTYMAS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BALTYMAS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BALTYMAS

BALTMYAS, founded in 2011, is a pioneering biotech company with a focus on the production of native recombinant proteins in yeast. Their slogan, "Excellence in native recombinant proteins," reflects their commitment to high-quality and innovative solutions. The team, comprised of scientists and bioengineers, boasts 10 years of expertise in developing cutting-edge technologies for the biotechnology, health care, and pharmaceutical industries. Based in Lithuania, the company has notched significant achievements in its niche. Our analysis recognizes BALTMYAS as a promising player in the biotech landscape, harnessing the potential of native recombinant proteins with a distinct level of expertise. With their established track record and strategic positioning in Lithuania, the company presents an attractive investment opportunity in the ever-growing biotech sector. As they continue to pave the way for advancements in native recombinant proteins, BALTMYAS is poised to capture the attention of investors seeking innovative ventures in the biotech, health care, and pharmaceutical domains.

Business keywords: biotech, recombinant proteins, yeast expression, viral antigens, bioengineering, technology development, eye drops, calreticulin, AMD treatment, rBSA technology, protein production, scientists, human chaperones, innovation

No funding data available for BALTYMAS yet.

BALTYMAS Alternatives & Competitors

View All Alternatives
BALTYMAS vs

Pioneering accessible and affordable biological medicines through advanced protein and antibody tech...

Series A
91 employees
Biotechnology, Health Care
BALTYMAS vs

Hawaii Biotech, Inc. (HBI) is a privately held biotechnology company focused on the research and dev...

Grant
15 employees
Biotechnology, Health Care
BALTYMAS vs

Changing the World with Silkworms

Series B
10 employees
Biotechnology, Pharmaceutical

FAQ About BALTYMAS

Excellence in native recombinant proteins
BALTYMAS was founded in 2011.
BALTYMAS is headquartered in Lithuania.
BALTYMAS operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on biotech, recombinant proteins, yeast expression and viral antigens.
BALTYMAS has approximately 4 employees.
Top alternatives and competitors to BALTYMAS include 神州细胞工程有限公司, Hawaii Biotech, Inc., KAICO Ltd., Dima Biotechnology, Y-Biologics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BALTYMAS and 神州细胞工程有限公司 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BALTYMAS, https://bouncewatch.com/company/baltymas, updated 25 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout